Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2003
05/22/2003CA2468497A1 Heterocyclic derivatives of glycinamide and their medical use
05/22/2003CA2467267A1 Phenyl substituted triazoles and their use as selective inhibors of akl5 kinase
05/22/2003CA2467229A1 Dexrazoxane for treating antitumor-induced cardiotoxicity
05/22/2003CA2467167A1 High-concentration lidocaine compositions and methods for their preparation
05/22/2003CA2467081A1 Pyrazole derivatives as psychopharmaceuticals
05/22/2003CA2467068A1 C-5 modified indazolylpyrrolotriazines
05/22/2003CA2467061A1 Sustained release film preparation for local administration comprising prostaglandin derivative as active ingredient
05/22/2003CA2467056A1 Carotenoid composition and method for protecting skin
05/22/2003CA2466975A1 Macrolides
05/22/2003CA2466971A1 Benzimidazol- or indol-aminoacetonitrile derivatives for parasite control
05/22/2003CA2466962A1 Aryl aniline beta-2 adrenergic receptor agonists
05/22/2003CA2466955A1 Benzotriazepines as gastrin and cholecystokinin receptor ligands
05/22/2003CA2466790A1 Preventive or therapeutic agent for pruritus
05/22/2003CA2466665A1 Method to treat cystic fibrosis
05/22/2003CA2466659A1 Anticancer agents
05/22/2003CA2466632A1 Injectable depot compositions and uses thereof
05/22/2003CA2466519A1 Method for treating autoimmune diseases
05/22/2003CA2466508A1 Method and pharmaceutical preparations for reducing the activity of cells
05/22/2003CA2466504A1 Oral dosage form of a sulfonamide prodrug
05/22/2003CA2466465A1 Nk1 antagonists
05/22/2003CA2466440A1 Cannabinoid receptor ligands
05/22/2003CA2466422A1 Methods and compositions for use of (s)-bisoprolol
05/22/2003CA2466355A1 Neurotransmitter balance chemotherapy
05/22/2003CA2466344A1 Azabicyclic-phenyl-fused-heterocyclic compounds and their use as alpha7 nachr ligands
05/22/2003CA2466115A1 Cyanoalkylamino derivatives as protease inhibitors
05/22/2003CA2466055A1 Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer
05/22/2003CA2465893A1 Polycyclic guanine derivative phosphodiesterase v inhibitors
05/22/2003CA2465861A1 Carboxylic acid derivative compounds and drugs containing the same as the active ingredient
05/22/2003CA2465776A1 Use of specific dose of fondaparinux sodium for the treatment of acs
05/22/2003CA2465334A1 Aspirin-containing transdermal pharmaceutical composition for the treatment of calcification
05/22/2003CA2464863A1 N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation
05/22/2003CA2464861A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5)
05/22/2003CA2464419A1 Benzimidazoles useful as protein kinase inhibitors
05/22/2003CA2464347A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5)
05/22/2003CA2463970A1 Monohydroxycarbamazepine for use in the preparation of a medicament for the treatment of affective and attention disorder and neuropathic pain
05/22/2003CA2463481A1 Three-dimensional suspension printing of dosage forms
05/22/2003CA2461577A1 Novel c-3 s/o- and s/n formaldehe acetal derivatives of cephalosporins and their use as antibiotics
05/22/2003CA2460027A1 Medical devices having antimicrobial coatings thereon
05/21/2003EP1312679A1 Recombinant MVA virus, and the use thereof
05/21/2003EP1312678A1 Recombinant MVA virus, and the use thereof
05/21/2003EP1312611A1 Method of continuously degrading protein
05/21/2003EP1312609A1 Boronic ester and acid compounds, synthesis and uses
05/21/2003EP1312608A2 Discodermolide analogues and their pharmaceutical use
05/21/2003EP1312607A1 Dithiocarbamate derivatives and their use as antibacterial agents
05/21/2003EP1312602A1 Amidino derivatives, and anticoagulants and thrombosis therapeutic agents containing them
05/21/2003EP1312379A1 Fibrinogen lowering agents
05/21/2003EP1312374A1 Sugar absorption inhibitors and process for producing the same
05/21/2003EP1312373A1 Antiallergic agents, drugs, foods, drinks or cosmetics containing them and process for producing the same
05/21/2003EP1312372A1 Cytokine production inhibitors, agents for protecting and promoting liver function, anti-inflammatory agents, immunosuppressants, drugs, cosmetics, foods and food materials
05/21/2003EP1312369A1 Cardiac arrest fluid
05/21/2003EP1312368A1 Composition comprising mesalazine for the treatment of inflammatory bowel diseases
05/21/2003EP1312367A1 Heterocyclo-alkylsulfonyl pyrazolesa and their use as COX-2 inhibitors
05/21/2003EP1312366A1 Aqueous pharmaceutical compositions
05/21/2003EP1312365A1 Pteridinones for the treatment of erectile dysfunctions
05/21/2003EP1312364A1 Cytokine production inhibitors
05/21/2003EP1312363A1 Methods of treatment and kits comprising a growth hormone secretagogue
05/21/2003EP1312362A1 Method for the suppression of visceral pain by regulating T-type calcium channel
05/21/2003EP1312361A1 Antipruritic agent
05/21/2003EP1312360A1 Analgesic/antiinflammatory patches for topical use
05/21/2003EP1312359A2 Use for 1,3-propanediol compounds
05/21/2003EP1312358A1 Solid pharmaceutical compositions for oral administration comprising itraconazole
05/21/2003EP1312356A1 Aqueous suspension preparations
05/21/2003EP1312355A1 Water-soluble non-effervescent pharmaceutical compositions comprising non-steroidal anti-inflammatory drugs
05/21/2003EP1311694A1 Pyruvate:nadp+ oxidoreductase and uses thereof
05/21/2003EP1311686A2 Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization
05/21/2003EP1311679A2 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
05/21/2003EP1311677A2 Regulation of human p2y1-like g protein-coupled receptor
05/21/2003EP1311673A2 Compositions and methods for the therapy and diagnosis of prostate cancer
05/21/2003EP1311672A1 New sequences
05/21/2003EP1311668A2 Compositions and methods for the diagnosis and treatment of tumor
05/21/2003EP1311660A1 METHOD OF SCREENING FOR INHIBITORS OF HUMAN FATTY ACID-CoA LIGASE 4
05/21/2003EP1311534A1 Thioether-sulphamate steroids as steroid sulphatase inhibitors and anti-cancer compounds
05/21/2003EP1311533A1 17-aryl-linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase
05/21/2003EP1311532A1 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase
05/21/2003EP1311531A1 Steroid derived antibiotics
05/21/2003EP1311525A2 Composition and method for inhibiting platelet aggregation
05/21/2003EP1311524A2 5'-deoxy-n-(substituted oxycarbonyl)-5-fluorocytosine and derivatives thereof, method of preparing same, and anticancer composition comprising same as active ingredients
05/21/2003EP1311522A1 New immunoeffector compounds
05/21/2003EP1311519A1 Thermosensitive cyclotriphosphazene-platinum complex conjugate, its preparation method and anticancer agent containing the same
05/21/2003EP1311511A1 Pyrazole compounds, pharmaceutical compositions, and methods for modulating or inhibiting erab or hadh2 activity
05/21/2003EP1311510A1 2,5-dihydro-pyrazolo[3,4-d]pyrimidin-4-ones with an anticonvulsive action and methods for producing the same
05/21/2003EP1311508A2 Novel beta-amyloid inhibitors, method for producing the same and the use thereof as medicaments
05/21/2003EP1311507A1 Fused pyrazole derivatives being protein kinase inhibitors
05/21/2003EP1311505A2 Quinuclidine-substituted heteroaryl moieties for treatment of disease ( nicotinic acetylcholine receptor ligands )
05/21/2003EP1311504A1 Tetrazolyl-phenyl acetamide glucokinase activators
05/21/2003EP1311503A1 Chromenone derivatives and their use for treating diseases in conjunction with 5-hta1 receptors and/or dopamine d2 receptors
05/21/2003EP1311502A1 Bicyclic heteroaromatic derivatives for the treatment of immune and inflammatory disorders
05/21/2003EP1311500A2 Indole, azaindole and indazole derivatives having vegf inhibiting activity
05/21/2003EP1311499A2 Bicyclic compounds as h3 receptor ligands
05/21/2003EP1311497A1 Heterocyclic fluoroalkenyl thioethers and the use thereof as pesticides (iv)
05/21/2003EP1311496A1 Heterocyclic fluoroalkenyl thioethers and the use thereof as pesticides (iii)
05/21/2003EP1311491A1 Use of triazinetrione sulfones for combating coccidiosis
05/21/2003EP1311489A1 Biphenyl derivatives and the use thereof as integrin inhibitors
05/21/2003EP1311488A1 Substituted imidazoles as tafia inhibitors
05/21/2003EP1311486A1 Uses of thaliporphine or its derivatives in treatment of cardiac diseases and preparation of same
05/21/2003EP1311485A1 Processes for preparing cilostazol
05/21/2003EP1311484A1 Biphenyl derivatives and the use thereof as integrin inhibitors
05/21/2003EP1311482A2 Non-imidazole aryloxypiperidines as h3 receptor ligands
05/21/2003EP1311480A1 New amidino derivatives and their use as thrombin inhibitors
05/21/2003EP1311478A1 Novel thiourea compounds and the pharmaceutical compositions containing the same
1 ... 5461 5462 5463 5464 5465 5466 5467 5468 5469 5470 5471 5472 5473 5474 5475 5476 5477 5478 5479 5480 5481 ... 7860